Swiss drug major Roche has launched two new medicines in India to treat breast cancer, claiming increased survival benefit and improved quality of life for patients.
“The new drugs, ‘Perjeta’ and ‘Kadcyla’, have been shown to both extend survival and improve quality of life in their approved applications for metastatic HER2-positive breast cancer,” Roche Pharma India said in a statement.
The company, however, did not share the pricing details of the two drugs.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.